Rockwell Medical, Inc.
RMTI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $43,230 | $29,096 | $38,542 | $67,071 |
| - Cash | $13,610 | $12,482 | $11,391 | $15,662 |
| + Debt | $10,884 | $14,007 | $12,868 | $13,535 |
| Enterprise Value | $40,504 | $30,621 | $40,019 | $64,944 |
| Revenue | $15,927 | $16,071 | $18,914 | $24,665 |
| % Growth | -0.9% | -15% | -23.3% | – |
| Gross Profit | $2,272 | $2,503 | $3,042 | $3,631 |
| % Margin | 14.3% | 15.6% | 16.1% | 14.7% |
| EBITDA | -$1,407 | -$653 | -$699 | $76 |
| % Margin | -8.8% | -4.1% | -3.7% | 0.3% |
| Net Income | -$1,753 | -$1,492 | -$1,515 | -$756 |
| % Margin | -11% | -9.3% | -8% | -3.1% |
| EPS Diluted | -0.05 | -0.044 | -0.044 | -0.023 |
| % Growth | -14.9% | 2% | -93% | – |
| Operating Cash Flow | -$1,307 | $1,844 | -$3,487 | $865 |
| Capital Expenditures | -$229 | -$164 | -$63 | -$395 |
| Free Cash Flow | -$1,536 | $1,680 | -$3,550 | $470 |